Xenon Pharmaceuticals Inc.
For the period ended Dec 31, 2025. Filed Feb 26, 2026.
View on SEC.govAbout this filing
A company's yearly report to the SEC, with audited financial statements. It is the fullest account a company gives of its business, its finances and the risks it sees.
FY2025 · Filed Feb 26, 2026
Extracted filing text, with the paragraph anchors used by the comparison.
See the whole filing, with its images and exhibitsContents
Signatures
POWER OF ATTORNEY
Each person whose signature appears below hereby constitutes and appoints Dawn Svoronos, Ian Mortimer and Thomas P. Kelly, and each of them severally, as his or her true and lawful attorneys-in-fact and agents, with full power to act without the other and with full power of substitution and resubstitution, for him or her and in his or her name, place and stead, in any and all capacities (including his or her capacity as a director and/or officer of Xenon Pharmaceuticals Inc.) to sign any and all amendments and supplements to this report, and any and all other instruments necessary or incidental in connection herewith, and to file the same, with all exhibits thereto, and all other documents in connection therewith, with the Commission.
Pursuant to the requirements of the Securities Exchange Act of 1934, this report has been signed below by the following persons on behalf of the Registrant and in the capacities and on the dates indicated.
| Signature | Title | Date |
|---|---|---|
| /s/ Ian MortimerIan Mortimer | President, Chief Executive Officer and Director (Principal Executive Officer) | February 26, 2026 |
| /s/ Thomas P. Kelly | Chief Financial Officer (Principal Financial and Accounting Officer) | February 26, 2026 |
| Thomas P. Kelly | ||
| /s/ Dawn Svoronos | Chair of the Board of Directors | February 26, 2026 |
| Dawn Svoronos | ||
| /s/ Gillian Cannon | Director | February 26, 2026 |
| Gillian Cannon | ||
| /s/ Steven Gannon | Director | February 26, 2026 |
| Steven Gannon | ||
| /s/ Elizabeth Garofalo | Director | February 26, 2026 |
| Elizabeth Garofalo | ||
| /s/ Justin Gover | Director | February 26, 2026 |
| Justin Gover | ||
| /s/ Patrick Machado | Director | February 26, 2026 |
| Patrick Machado | ||
| /s/ Gary Patou | Director | February 26, 2026 |
| Gary Patou | ||
The text of this filing, as the company filed it with the SEC, without its images or exhibits. This is not investment advice.